Glucagon-like peptide analogues for type 2 diabetes mellitus
At 36 weeks, weight loss ranged from 9.4% to 14.7% in GLP-1 patients, compared with 2.3% in the placebo group
Concise Review: Prostate Cancer Stem Cells: Current Understanding
GSH depletion can trigger ferroptosis, which has been exploited in cancer treatments [17], and supplementation with GSH is utilized by glutathione peroxidase 4 (GPX4) to prevent lipid peroxidation, in turn inhibiting ferroptosis
read more Close window Immuno-Grade GLP1 Receptor Antibodies The glucagon-like peptide-1 receptor (GLP1) is a class B G protein-coupled receptor that plays a crucial role in the regulation of glucose metabolism and energy balance
We previously described a novel GLP-1 analogue consisting of the fusion of active GLP-1 and IgG heavy chain constant regions (GLP-1/IgG-Fc), and showed that in vivo expression of the protein, via electroporation-enhanced intramuscular plasmid-based gene transfer, normalized blood glucose levels in T2D-prone db/db mice